BOLD-100 treatment induces systemic lipid crosstalk in metastatic colorectal carcinoma patients in a combination treatment with FOLFOX
CC-BY 4.0
We are happy to share our published exploratory biomarker study of metastatic colorectal carcinoma patients, who were treated with BOLD-100 and…